Why this pharmacy benefit manager is using a value-based model to tackle rising drug costs

“Healthcare in this country, and PBMs specifically, have been focused on volume because it’s a very retail-centric model,” says Ganesh. “EmpiRx wants to drive a different paradigm, where it's not about volume but about driving the right clinical outcomes and financial outcomes.”
Why this pharmacy benefit manager is using a value-based model to tackle rising drug costs

With half of the American population receiving health insurance from their jobs, there’s no doubt that employers are at the forefront of rising healthcare costs. But many employers may feel helpless in the face of industries seemingly out of their control — and the trillion-dollar pharmaceutical industry is no exception.

Read More

Share:

Share on linkedin

More Posts

Case Study Highlighting a Clinically Appropriate Alternative to Optimize Waste

Real value is achieved by focusing on whole-person health and clinical appropriateness. In this study, one patient case led to more than $48,000 in clinical savings while managing the patient’s quality of life on the new medication recommendation! You’ll see how our population health model drove over $4MM in savings and personalized patient care since client implementation.

Read More

Contact Us

Ready to learn about a different way to approach your pharmacy benefits? 

Request our client success case studies.

Fill in your details to receive the EmpiRx Health case studies.

  • This field is for validation purposes and should be left unchanged.